Susquehanna Fundamental Investments, LLC Coherus Bio Sciences, Inc. Transaction History
Susquehanna Fundamental Investments, LLC
- $2.14 Trillion
- Q1 2024
A detailed history of Susquehanna Fundamental Investments, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 146,231 shares of CHRS stock, worth $252,979. This represents 0.02% of its overall portfolio holdings.
Number of Shares
146,231Holding current value
$252,979% of portfolio
0.02%Shares
9 transactions
Others Institutions Holding CHRS
# of Institutions
148Shares Held
82.9MCall Options Held
184KPut Options Held
255K-
Black Rock Inc. New York, NY11.2MShares$19.4 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.4MShares$18 Million0.85% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$17.4 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U07.38MShares$12.8 Million0.1% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$5.25 Million0.31% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $134M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...